Related Experiment Video
Updated: May 21, 2026

13:05
Expression of Recombinant Cellulase Cel5A from Trichoderma reesei in Tobacco Plants
Published on: June 13, 2014
Improving cellulase production in Trichoderma koningii through RNA interference on ace1 gene expression
Shao-Wen Wang1, Miao Xing, Gang Liu
1College of Life Science, Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen University, Shenzhen 518060, China.
Journal of Microbiology and Biotechnology
|June 21, 2012
Summary
Ribonucleic acid interference (RNAi) effectively silenced the ACE1 gene in Trichoderma koningii, boosting cellulase and xylanase production. This demonstrates RNAi
Area of Science:
- Molecular Biology
- Mycology
- Biotechnology
Background:
- Filamentous fungi are crucial for industrial enzyme production.
- Gene knockout is challenging in some fungi, limiting strain improvement.
- Ribonucleic acid interference (RNAi) offers sequence-specific gene knockdown potential.
Purpose of the Study:
- To verify the function of the cellulase expression repressor ACE1 in Trichoderma koningii.
- To enhance cellulase and xylanase productivity using RNAi-mediated gene silencing.
- To investigate the regulatory role of ACE1 in gene expression.
Main Methods:
- Construction and transformation of an expression cassette for ACE1-specific double-stranded RNA (dsRNA).
- Selection of transformants with successful ACE1 gene silencing in Trichoderma koningii.
- Analysis of cellulase, xylanase, XYR1, and CRE1 gene expression levels.
Main Results:
- ACE1 gene silencing was successfully achieved in Trichoderma koningii.
- Silencing ACE1 led to elevated expression of cellulase and xylanase genes.
- Downregulation of ACE1 increased XYR1 expression but did not affect CRE1 expression.
- Enhanced production of total proteins, cellulase, and xylanase was observed.
Conclusions:
- ACE1 acts as a repressor of xylanase 1 (XYR1) transcription in Trichoderma koningii.
- ACE1 is not involved in the regulation of CRE1 expression.
- ACE1 is a viable target gene for improving enzyme production in Trichoderma koningii.
- RNAi is an effective tool for enhancing the properties of industrial fungi.
Related Concept Videos
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

